Search for: "Ortho McNeil Neurologics"
Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
24 Oct, 2006 9:55 pm
Ortho-McNeil Neurologics, a unit of Johnson & Johnson,
announced in a press release today that it won a preliminary injunction against Mylan in its patent infringement case aimed to protect Topamax (topiramate) from generic competition. ...
this year, Judge Chesler dismissed Mylan's inequitable conduct, non-enablement, and indefiniteness allegations on summary judgment. Ortho-McNeil filed its motion for a preliminary injunction last July "to preserve the status quo" and prevent an
at-risk launch ...
15 Apr 8:56 pm
... Resolution Announced in Johnson & Johnson Razadyne® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of
all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne® ER. The dispute stemmed from
ANDA filings made in ...
27 Oct, 2006 9:43 am
... Mylan product or a final court decision concerning the pending litigation between Pfizer and Mylan. In Ortho-McNeil Pharmaceutical v. Mylan Laboratories (04-cv-01689), ... ordinary skill in the art would have been motivated to select DPF to sulfamoylate.
Ortho argued that the claimed invention would not have been obvious based on four ... 1) Unexpected results; (2) Commercial success - Topamax®
is the top-selling branded neurology product in the US.; (3) Copying - FDA has received nine ANDA applications ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!